KR100592482B1 - Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them - Google Patents

Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them Download PDF

Info

Publication number
KR100592482B1
KR100592482B1 KR1020040056020A KR20040056020A KR100592482B1 KR 100592482 B1 KR100592482 B1 KR 100592482B1 KR 1020040056020 A KR1020040056020 A KR 1020040056020A KR 20040056020 A KR20040056020 A KR 20040056020A KR 100592482 B1 KR100592482 B1 KR 100592482B1
Authority
KR
South Korea
Prior art keywords
licorice
extract
ethanol
liquiritigenin
content
Prior art date
Application number
KR1020040056020A
Other languages
Korean (ko)
Other versions
KR20060039036A (en
Inventor
송경식
이인구
이경복
유영춘
정신교
Original Assignee
경북대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경북대학교 산학협력단 filed Critical 경북대학교 산학협력단
Priority to KR1020040056020A priority Critical patent/KR100592482B1/en
Publication of KR20060039036A publication Critical patent/KR20060039036A/en
Application granted granted Critical
Publication of KR100592482B1 publication Critical patent/KR100592482B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 감초 또는 감초추출물에 당가수분해활성을 갖는 미생물, 또는 미생물 조효소액을 이용하여 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴 유발 독성제거 등의 활성화합물인 리퀴리티게닌(liquiritigenin) 함량을 증강하는 방법과, 상기방법에 의하여 처리된 감초, 또는 감초추출물로부터 활성화합물(리퀴리티게닌)을 정제하는 방법에 관련된다.The present invention is an active compound, such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, elimination of cadmium-induced toxicity by using microorganisms having sugar hydrolysis activity or liquor coenzyme in licorice or licorice extract (liquiritigenin) content and a method for purifying the active compound (liquirigenin) from licorice, or licorice extract treated by the method.

이에 따라 본 발명은, 감초 또는 감초추출물로부터 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴 유발 독성제거 등의 활성화합물인 리퀴리티게닌(liquiritigenin) 함량을 증강하고, 이 추출물로부터 활성화합물(리퀴리티게닌)을 정제하는 방법을 제공함으로서, 항치매, 항산화, 항암, 항균, 해독등의 기능을 갖는 건강기능성 식품 조성물 및 치료와 예방을 위한 약학적 조성물 그리고 노화방지, 자외선차단 등의 기능을 갖는 기능성 향장품을 제공하는 효과를 제공한다.Accordingly, the present invention is to enhance the content of liquiritigenin (active compound, such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, cadmium-induced toxicity removal from licorice or licorice extract, active from this extract) By providing a method for purifying a compound (liquirithiinin), a health functional food composition having the functions of anti-dementia, antioxidant, anti-cancer, antibacterial, detoxification, pharmaceutical composition for treatment and prevention and anti-aging, sun protection, etc. Provides the effect of providing a functional cosmetics having the function of.

감초, 발효, 미생물, 리퀴리티게닌, 추출, 정제Licorice, Fermentation, Microorganism, Liquirigenin, Extraction, Purification

Description

감초 및 감초추출물 중의 리퀴리티게닌 함량을 증강하는 방법과 추출물에서의 활성화합물 정제방법{Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them} Method for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them}

도 1은 본 발명에 따른 감초 또는 감초추출물로부터 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴유발 독성제거 등의 활성 화합물인 리퀴리티게닌(liquiritigenin) 함량을 증강하는 방법과 추출물에서 활성화합물 정제방법을 보인 흐름도.1 is a method and extract for enhancing the content of liquiritigenin, an active compound such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, cadmium-induced toxicity removal from licorice or licorice extract according to the present invention Flow chart showing method for purifying active compound.

도 2는 본 발명에 따른 리퀴리티게닌(liquiritigenin)의 화학적 구조식을 나타내는 도면.2 is a view showing the chemical structural formula of liquiritigenin (liquiritigenin) according to the present invention.

도 3은 본 발명에 따른 감초 또는 감초추출물로부터 미생물유래 효소액 처리 후 수추출물 중 리퀴리티게닌 함량의 변화를 처리전과 비교한 HPLC 크로마토그램을 나타내는 도면.Figure 3 is a view showing the HPLC chromatogram comparing the change in the content of the liquid liquerigenin in the water extract after treatment with licorice or licorice extract according to the present invention microbial derived enzyme solution.

도 4는 본 발명에 따른 감초 또는 감초추출물로부터 미생물 조효소액 처리 후 에탄올 추출물 중 리퀴리티게닌 함량의 변화를 처리전과 비교한 HPLC 크로마토그램을 나타내는 도면.Figure 4 is a view showing the HPLC chromatogram comparing the change in the liquid content of liqueurinine in ethanol extract after treatment with the microorganism coenzyme solution from licorice or licorice extract according to the present invention.

도 5는 본 발명에 따른 효소처리 후 생성되는 리퀴리티게닌의 함량을 시간별 로 측정한 결과를 나타내는 도면.Figure 5 is a view showing the result of measuring the content of the liquid liquerigenin produced after the enzyme treatment according to the present invention over time.

도 6은 본 발명에 따른 리퀴리티게닌의 수소 핵자기 공명 스펙트럼을 나타내는 도면.Figure 6 is a view showing the hydrogen nuclear magnetic resonance spectrum of the liquiditinein according to the present invention.

도 7은 본 발명에 따른 리퀴리티게닌의 탄소 핵자기 공명 스펙트럼을 나타내는 도면.7 is a view showing the carbon nuclear magnetic resonance spectrum of the liquiditinein according to the present invention.

본 발명은 감초 또는 감초추출물로부터 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴 유발 독성제거 등의 활성화합물인 리퀴리티게닌(liquiritigenin) 추출물 함량을 증강하고, 이 추출물로부터 활성화합물(리퀴리티게닌)을 정제하는 방법에 관한 것이다.The present invention enhances the content of the extract of liquiritigenin, an active compound such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, cadmium-induced toxicity removal from licorice or licorice extract, Liqueurinine).

보다 상세하게는 장미목 콩과에 속하는 감초(Glycyrrhiza uralensis) 및 이의 근연식물인 시베리아 감초(G. globra var. glandifera), 에스파냐산 감초(G. globra)등의 동속식물 또는 이들의 수추출물, 유기용매추출물로부터 전통발효식품에서 분리한 아스페루기루스 가와지(Aspergillus kawachii), 이와 유사한 활성을 갖는 미생물, 또는 이들이 생성하는 글루코시다아제(glucosidase)를 포함하는 당 가수분해 효소 등으로 처리하여 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴유발 독성제거 등의 활성을 갖는 리퀴리티게닌(liquiritigenin)의 함량을 높이고, 상기 방법으로 처리한 추출물에서 열수 추출, 에탄올 추출, 용해도 차, 실리카 젤 및 세파덱스 크로마토그라피 등으로 활성화합물을 분리 정제하고자 하는 방법에 관한 것이다.More specifically, Glycyrrhiza uralensis belonging to the Rosacea legume and its related plant, Siberian licorice (G. globra var. Glandifera), Espanola licorice (G. globra) or the like, or their extracts, organic solvents Anti-dementia by treatment with Aspergillus kawachii, microorganisms having similar activity, or sugar hydrolase including glucosidase produced by the extract from traditional fermented foods, Increasing the content of liquiritigenin, which has antimicrobial, antioxidant, antiangiogenic, anti-skin cancer, and cadmium-induced toxicity, and extracting hot water, ethanol, soluble tea, silica gel And it relates to a method to separate and purify the active compound by Sephadex chromatography.

일반적으로, 감초(Glycyrrhiza uralensis)는 장미목 콩과의 여러해살이풀로 뿌리는 적갈색으로 땅속 깊이 내려가고 모난 줄기는 1∼1.5m 정도로 곧게 자란다. 잎은 어긋나며 달걀형이고 끝이 뾰족하다. 잎의 길이는 2∼5cm, 너비는 1∼3cm이며 톱니는 없다. 꽃은 콩과 비슷하며 여름에 남자색으로 피며 총상화서이다. In general, licorice (Glycyrrhiza uralensis) is a perennial herbaceous perennial herbaceous reddish-brown, descending deep into the ground, with stalks growing straight up to 1-1.5m. Leaves are alternate, egg-shaped, pointed. Leaves are 2-5cm long, 1-3cm wide, without teeth. Flowers are similar to beans and bloom in male color in summer.

이러한, 감초에 소량 함유된 것으로 알려진 리퀴리티게닌(liquiritigenin)은 문헌에 보고된 바에 의하면 항치매 , 항균, 항산화, 항혈관신생, 항피부암, 카드뮴유발독성제거 등의 다양한 생리활성을 나타내는 것으로 알려져 있다. Liquiritigenin, which is known to be contained in small amounts in licorice, has been reported in the literature to exhibit various physiological activities such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, elimination of cadmium-induced toxicity. have.

그러나, 상기 감초의 리퀴리티게닌과 관련된 기존의 발명으로는 일본, 중국 등의 국제특허가 있으나, 상기 특허에서 개시된 방법은 단순히 감초, 또는 다른 식물체로부터 각종 용매를 이용하거나 이온교환수지 등을 통하여 정제하는 방법이고, 국내에는 아직도 감초의 리퀴리티게닌과 관련된 특허는 없는 것으로 알고 있다.However, although the existing inventions related to the liquiriginine of licorice have international patents such as Japan and China, the method disclosed in the above patent is simply by using various solvents from licorice or other plants or through ion exchange resins. It is a method of purification, and it is known that there is no patent related to liquiriginine of licorice in Korea.

이에 따라 본 고안은 상기와 같은 종래의 문제점을 근본적으로 해결하기 위한 것으로서, 감초 또는 감초추출물로부터 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴 유발 독성제거 등의 활성화합물인 리퀴리티게닌(liquiritigenin) 추출물 함량을 증강하고, 이 추출물로부터 활성화합물(리퀴리티게닌)을 정제하는 방법을 제공함으로서, 항치매, 항산화, 항암, 항균, 해독등의 기능을 갖는 건강기능성 식품 조성물 및 치료와 예방을 위한 약학적 조성물 그리고 노화방지, 자외선 차단 등의 기능을 갖는 기능성 향장품을 제공하려는데 그 목적이 있다.Accordingly, the present invention is intended to fundamentally solve the conventional problems as described above, and is an active compound, such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, removal of cadmium-induced toxicity from licorice or licorice extract. By providing a method for enhancing the content of extract of liquiritigenin and purifying the active compound (liquirigenin) from the extract, the health functional food composition and treatment having the functions of anti-dementia, antioxidant, anticancer, antibacterial, detoxification, etc. And to provide a pharmaceutical composition for the prevention and functional cosmetics having the function of anti-aging, sun protection, and the like.

이하, 첨부된 도면 1을 참조하여 감초 또는 감초추출물로부터 리퀴리티게닌(liquiritigenin)함량을 증강하는 방법의 일실시예에 대하여 설명하면 다음과 같다.Hereinafter, an embodiment of a method of enhancing liquiritigenin content from licorice or licorice extract will be described with reference to the accompanying drawings.

우선, 본 발명에 사용한 미생물과 이로부터 얻는 조효소액의 특성은 다음과 같다. 본 발명에 사용한 미생물은 된장으로부터 분리하였으며 분류학적으로 Aspergillus kawachii로 명명되는 곰팡이다. 이 곰팡이는 밀기울과 글루코즈 용액을 혼합한 배지에서 배양하였으며 30℃에서 5∼15일간 배양하여 사용하거나, 이 배양체에 1∼1000m㏖(바람직하게는 100m㏖ 완충용액), 인산나트륨완충액 (pH 7.0)1∼100㎖(바람직하게는 30㎖)을 넣고, 4℃에서 1∼12시간(바람직하게는 5시간) 방치 후 거즈로 거르고 그 액을 1,000∼20,000rpm(바람직하게는 12,000 rpm)에서 1∼60분(바람직하게는 15분)간 원심분리한 다음 얻은 상등액을 효소액으로 사용한다. 효소액 중에는 각종 당가수분해 효소를 함유하고 있으며 그 중에서도 β-glucosidase 활성이 주를 이루고 있는 특성을 가진다.First, the characteristics of the microorganism used in the present invention and the crude enzyme solution obtained therefrom are as follows. The microorganism used in the present invention was isolated from doenjang and is a fungus named aspergillus kawachii. The fungus was cultured in a medium mixed with bran and glucose solution and used for 5 to 15 days at 30 ° C, or 1 to 1000 mmol (preferably 100 mmol buffer) and sodium phosphate buffer (pH 7.0). 1 to 100 ml (preferably 30 ml) is added, and left to stand at 4 ° C. for 1 to 12 hours (preferably 5 hours), then filtered with gauze and the solution is 1 to 1 at 1000 to 20,000 rpm (preferably 12,000 rpm). Centrifuge for 60 minutes (preferably 15 minutes) and then use the obtained supernatant as the enzyme solution. The enzyme solution contains various glycolytic enzymes, and among them, β-glucosidase activity has the main characteristics.

먼저, 감초, 또는 감초추출물에 대한 미생물 처리 및 이에 의해 생성되는 리퀴리티게닌의 추출, 정제를 위하여 세절한 감초 약 1kg을 100℃에서 물로 환류추출한 다음 여과하고, 여액을 동결건조하도록 한다.First, about 1 kg of fine licorice is refluxed with water at 100 ° C. for microbial treatment of licorice or licorice extract and the extraction and purification of the resulting liquiriginine, followed by filtration and freeze drying of the filtrate.

이후에, 상기 동결건조물 200g를 Aspergyllus kawachii로부터 얻은 조효소액 (단백질로서 26g)으로 처리하고 이를 37℃에서 12시간 정치한다. Subsequently, 200 g of the lyophilisate was treated with a crude enzyme solution (26 g as a protein) obtained from Aspergyllus kawachii and left standing at 37 ° C. for 12 hours.

그리고, 상기 배양물에 약 500㎖의 에탄올을 가한 다음 에탄올 가용성성분과 불용성 성분으로 나누고, 에탄올 가용성 성분을 감압농축하여 추출물 15g를 얻는다.Then, about 500 ml of ethanol is added to the culture, and the ethanol soluble component and the insoluble component are divided, and the ethanol soluble component is concentrated under reduced pressure to obtain 15 g of the extract.

이어서, 상기 추출물을 300㎖의 증류수에 분산시킨 다음 동량의 디클로로메탄으로 3회 분배추출하고 디클로로메탄에 가용성인 부분을 합하여 농축하여 200㎎을 얻는다.Subsequently, the extract was dispersed in 300 ml of distilled water, and then extracted three times with the same amount of dichloromethane. The combined portions soluble in dichloromethane were concentrated to obtain 200 mg.

그리고, 상기 디클로로메탄 가용성 분획에 대하여 실리카젤 컬럼크로마토그라피(머크사, Art No. 7734, 컬럼크기: 1.5×30cm, 용출액: 디클로로메탄-메탄올= 100-1부터 시작하여 1-1로 기울기를 주어 용출)하여 7개의 분획을 얻는다.In addition, silica gel column chromatography (Merck, Art No. 7734, column size: 1.5 × 30 cm, eluent: dichloromethane-methanol = 100-1 with respect to the dichloromethane soluble fraction given by 1-1 to give a slope Elute) to obtain 7 fractions.

이어서, 상기 7개의 분획 중 7번째 분획은 리퀴리티게닌을 다량 함유하고 있었으며, 디클로로메탄과 메탄올의 혼합용매에서 재결정화를 행함으로써 순수한 리퀴리티게닌 71.2㎎을 얻게 되는 것이다.Subsequently, the seventh of the seven fractions contained a large amount of liquirithiinin, and 71.2 mg of pure liquiritigenin was obtained by recrystallization in a mixed solvent of dichloromethane and methanol.

여기서, 상기 감초 또는 감초추출물로부터 함량을 증강한 리퀴리티게닌은 약학적, 향장품학적, 또는 식품학적 조성물로 허용되는 부형제, 담체, 희석제 등을 포함하므로, 쉽게 입수할 수 있는 성분들을 이용하여 공지의 방법에 따라 제제화할 수 있다.Herein, the liquirithiinin with an increased content from the licorice or licorice extract includes excipients, carriers, diluents, etc., which are acceptable as pharmaceutical, cosmetic, or food compositions, and thus, are well known using readily available ingredients. It can be formulated according to the method of.

일예로, 활성 성분을 담체와 혼합하거나, 담체로 희석하거나, 캡슐, 사셰, 종이 또는 다른 용기의 형태인 담체 내에 담을 수 있다. 여기서, 담체가 희석제의 역할을 할 경우에는 활성 성분을 위한 비히클, 부형제 또는 매질로 작용하는 고체, 반고체, 또는 액체 물질일 수 있다. 따라서, 제제는 정제, 환제, 분산제, 과립제, 엘릭서, 현탁제, 유화제, 용액, 시럽제, 에어로졸제, 연질 및 경질 젤라틴 캅셀제, 멸균 주사용액, 멸균 포장된 분말제 및 연고 등의 형태일 수도 있다.In one example, the active ingredient may be mixed with the carrier, diluted with the carrier, or contained within the carrier in the form of a capsule, sachet, paper or other container. Here, when the carrier serves as a diluent, it may be a solid, semisolid, or liquid substance which acts as a vehicle, excipient or medium for the active ingredient. Thus, the preparation may be in the form of tablets, pills, dispersants, granules, elixirs, suspensions, emulsifiers, solutions, syrups, aerosols, soft and hard gelatin capsules, sterile injectable solutions, sterile packaged powders and ointments.

한편, 담체, 부형제 및 희석제의 예로는 락토즈, 덱스트로즈, 슈크로즈, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산칼슘, 알지네이트, 젤라틴, 규산칼슘, 미세결정성 셀룰로즈, 폴리비닐피롤리돈, 셀룰로즈, 폴리비닐피롤리돈, 셀룰로즈, 물, 설탕시럽, 메틸셀룰로즈, 메틸 하이드록시 벤조에이트, 프로필 하이드록시 벤조에이트, 활석, 스테아트산 마그네슘 및 미네랄 오일 등이 있다.Examples of carriers, excipients and diluents include lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, Cellulose, polyvinylpyrrolidone, cellulose, water, sugar syrup, methylcellulose, methyl hydroxy benzoate, propyl hydroxy benzoate, talc, magnesium stearate and mineral oil.

더불어 상기 감초 또는 감초추출물의 리퀴리티게닌 추출물은 상기 성분들 외에도 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다.In addition, the licorithigenin extract of the licorice or licorice extract may further include lubricants, wetting agents, sweeteners, flavoring agents, emulsifiers, suspending agents, preservatives and the like in addition to the components.

따라서, 본 발명의 감초 또는 감초추출물의 리퀴리티게닌 추출물은 환자에게 투여된 후 활성 성분을 급속하게, 지속적으로 또는 지연시켜 방출하도록 당분야의 공지 기술들을 이용하여 제제화할 수 있으며, 그 약학적, 향장품학적, 또는 식품학적 조성물은 경구 또는 비경구 투여될 수 있다.Accordingly, the liquiriginine extract of the licorice or licorice extract of the present invention can be formulated using known techniques in the art to rapidly, continuously or delayed release the active ingredient after administration to a patient, The cosmetic, cosmetic or food composition may be administered orally or parenterally.

예를 들어 활성 화합물의 1일 투여량은 통상적으로 체중 1 kg 당 약 0.1내지 20 mg 범위이며, 기능성 식품으로 사용될 경우 물, 또는 에탄올 추출물로서 100 mg 내지 10 g의 범위다.For example, daily dosages of active compounds typically range from about 0.1 to 20 mg per kg of body weight and range from 100 mg to 10 g as water or ethanol extract when used as a functional food.

한편, 상기 감초의 리퀴리티게닌 추출물 함량을 증강된 추출물에서의 활성화합물 정제방법은,On the other hand, the active compound purification method in the extract enhanced the content of the liquirithigenin extract of licorice,

당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리한 감초를 열수 또는 에탄올로 추출하거나, 감초를 열수, 또는 에탄올로 추출한 후 농축하여 추출물에 대하여 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리하여 조추출물을 얻는 단계와; 상기 단계에 의해 얻어진 조추출물을 그대로 사용하거나, 에탄올에 분산시켜 에탄올 가용부와 불용부로 나누는 단계와; 상기 단계에 의해 분리된 에탄올 가용부를 농축한 후 물에 분산시켜 디클로로메탄, 클로로포름, 에틸아세테이트로 분배 추출한 뒤 농축하여 유기용매 가용성 분획을 얻은 단계와; 상기 단계에 의해 분리된 유기용매 가용성 분획을 농축하여 실리카젤, 역상실리카젤, 고속액체, 세파덱스 크로마토그라피를 이용하여 항치매, 항산화, 항암, 항균, 해독 활성을 갖는 리퀴리티게닌을 정제하는 단계;로 진행되는 것이다.Microorganisms having a sugar hydrolytic activity or licorice treated with the microbial enzyme solution were extracted with hot water or ethanol, licorice was extracted with hot water or ethanol and concentrated to extract microorganisms having a sugar hydrolytic activity against the extract, or microbial enzyme liquid Processing to obtain a crude extract; Using the crude extract obtained by the step as it is or dispersing it in ethanol and dividing it into an ethanol soluble portion and an insoluble portion; Concentrating the ethanol soluble part separated by the above step, dispersing in water, partitioning extraction with dichloromethane, chloroform, ethyl acetate, and concentrating to obtain an organic solvent soluble fraction; Concentrating the organic solvent soluble fraction separated by the above step to purify the liqueuritinin having anti-dementia, antioxidant, anti-cancer, antibacterial, detoxification activity using silica gel, reversed phase silica gel, high-speed liquid, Sephadex chromatography It will proceed to step.

상기 진행단계에 의해 정제된 항치매, 항산화, 항암, 항균, 해독 활성을 갖는 화합물로서 감초, 또는 감초추출물에서 함량이 높아진 리퀴리티게닌은,As a compound having anti-dementia, antioxidant, anti-cancer, antibacterial, and detoxifying activity purified by the above step, licorice or licoriginine with high content in licorice extract,

문헌에 보고된 바에 의하면 항치매 (Pan, Xuan; Kong, Ling-Dong; Zhang, Yong; Cheng, Christopher H. K.; Tan, Ren-Xiang. In vitro inhibition of rat monoamine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Acta Pharmacologica Sinica (2000), 21(10), 949-953 및 Hatano, Tsutomu; Fukuda, Toshiyuki; Liu, Yanze; Noro, Tadataka; Okuda, Takuo. Phenolic constituents of licorice. IV. Correlation of phenolic constituents and licorice specimens from various sources, and inhibitory effects of licorice extracts on xanthine oxidase and monoamine oxidase. Yakugaku Zasshi (1991), 111(6), 311-21), 항균 (Hwang, Jae Ock; Ahn, Duk Kyun; Woo, Eun-Rhan; Kim, Hyoung Ja; Seo, Seon Hee; Park, Hokoon. Studies on the antibacterial constituents of Baenongtang. Natural Product Sciences (1998), 4(3), 130-135), 항산화 (Zou, Kun; Zhao, Yuying; Fu, Naiwu; Qiao, Liang; Zhang, Ruyi. Antioxidant constituents from Glycyrrhiza inflata Bat. root. Journal of Chinese Pharmaceutical Sciences (1996), 5(4), 182-185 및 Zou, Kun; Zhang, Ru-Yi. Constituents from Glycyrrhiza inflata and antioxidant activities of phenols from the roots of Glycyrrhiza. Journal of Chinese Pharmaceutical Sciences (1994), 3(1), 90), 항혈관신생 (Kobayashi, Shinjiro; Miyamoto, Takayuki; Kimura, Ikuko; Kimura, Masayasu. Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro. Biological & Pharmaceutical Bulletin (1995), 18(10), 1382-6), 항피부암 (Konoshima, Takao; Takasaki, Midori; Kozuka, Mutsuo; Inada, Akira; Nakanishi, Tsutomu; Tokuda, Harukuni; Matsumoto, Takeshi. Studies on inhibitors of skin tumor promotion (V). Inhibitory effects of flavonoids of Epstein-Barr virus activation. II. Shoyakugaku Zasshi (1989), 43(2), 135-41), 카드뮴유발독성제거 (Kim, Sang Chan; Byun, Sung Hui; Yang, Chae Ha; Kim, Chul Young; Kim, Jin Woong; Kim, Sang Geon. Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage). Toxicology (2004), 197(3), 239-251) 등의 다양한 생리 활성을 나타내는 것으로 알려져 있다. The literature reported that antidementia (Pan, Xuan; Kong, Ling-Dong; Zhang, Yong; Cheng, Christopher HK; Tan, Ren-Xiang.In vitro inhibition of rat monoamine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Acta Pharmacologica Sinica (2000), 21 (10), 949-953 and Hatano, Tsutomu; Fukuda, Toshiyuki; Liu, Yanze; Noro, Tadataka; Okuda, Takuo.Penolic constituents of licorice.IV.Correlation of phenolic constituents and licorice specimens from various sources, and inhibitory effects of licorice extracts on xanthine oxidase and monoamine oxidase.Yakugaku Zasshi (1991), 111 (6), 311-21), antibacterial (Hwang, Jae Ock; Ahn, Duk Kyun; Woo, Eun-Rhan ; Kim, Hyoung Ja; Seo, Seon Hee; Park, Hokoon.Studies on the antibacterial constituents of Baenongtang.Natural Product Sciences (1998), 4 (3), 130-135), antioxidant (Zou, Kun; Zhao, Yuying; Fu, Naiwu; Qiao, Liang; Zhang, Ruyi.Antioxidant constituents from Glycyrrhiza inflata Bat.root.Journal of Chinese P harmaceutical Sciences (1996), 5 (4), 182-185 and Zou, Kun; Zhang, Ru-Yi. Constituents from Glycyrrhiza inflata and antioxidant activities of phenols from the roots of Glycyrrhiza. Journal of Chinese Pharmaceutical Sciences (1994), 3 (1), 90), antiangiogenesis (Kobayashi, Shinjiro; Miyamoto, Takayuki; Kimura, Ikuko; Kimura, Masayasu.Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro.Biological & Pharmaceutical Bulletin (1995), 18 (10), 1382-6), anti-skin cancer (Konoshima, Takao; Takasaki, Midori; Kozuka, Mutsuo; Inada, Akira; Nakanishi, Tsutomu; Tokuda , Harukuni; Matsumoto, Takeshi.Study on inhibitors of skin tumor promotion (V) .Inhibitory effects of flavonoids of Epstein-Barr virus activation.II.Soyakugaku Zasshi (1989), 43 (2), 135-41), cadmium-induced toxicity Kim, Sang Chan; Byun, Sung Hui; Yang, Chae Ha; Kim, Chul Young; Kim, Jin Woong; Kim, Sang Geon.Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium-induced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage) .Toxicology (2004), 197 (3), 239-251), etc. It is known to exhibit various physiological activities.

이하, 감초, 또는 감초추출물에서 함량이 높아진 리퀴리티게닌을 정제방법의 일실시예에 대한 첨부된 도 1 및 도 2를 참조하여 설명한다.Hereinafter, licorice, or liquiriginin, the content of which is increased in licorice extract, will be described with reference to FIGS. 1 and 2.

본 발명의 활성 화합물은 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리한 감초, 혹은 감초추출액에 당가수분해활성을 갖는 미생물, 또는 그 미생물 조효소액을 처리한 혼합물로부터 분리, 정제함으로써 얻을 수 있으며 미생물, 또는 효소액의 처리 및 리퀴리티게닌의 추출, 분리, 부분정제는 예를 들어 다음과 같이 수행한다.The active compound of the present invention is obtained by separating and purifying from a microorganism having a sugar hydrolysis activity or a licorice treated with the microbial enzyme solution, or a microorganism having a sugar hydrolysis activity to a licorice extract, or a mixture of the microorganism coenzyme solution. Treatment of microorganisms or enzyme solutions and extraction, separation and partial purification of liquerigenin are carried out as follows, for example.

도 1 및 도 2에 도시된 바와 같이, 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리한 감초를 열수 또는 에탄올로 추출하거나, 감초를 열수, 또는 에탄올로 추출한 후 농축하여 추출물에 대하여 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리하여 조추출물을 얻는 단계이다.As shown in Figures 1 and 2, the licorice treated with a microorganism having a hydrolytic activity or its microbial enzyme solution is extracted with hot water or ethanol, or licorice is extracted with hot water or ethanol and concentrated to extract sugar It is a step of obtaining a crude extract by treating a microorganism having hydrolytic activity, or a microbial enzyme solution thereof.

여기서, 본 발명에 사용된 미생물은 본 발명자들에 의하여 된장으로부터 분리한 122종의 미생물로부터 선발되었으며, 선발기준은 β-glucosidase 활성이 가장 높은 것으로 하였다. 선발된 미생물은 분류학적으로는 Aspergillus kawachii로 동정되었다. 본 미생물은 밀기울 10g와 1% 글루코즈용액 10㎖를 반죽하여 100㎖ 삼각플라스크에 넣고 121℃에서 15분간 고압증자하여 멸균한 배지에 접종하여 배양하였다. 배양은 효소생산이 가장 왕성한 조건인 25℃, 100 rpm 진탕, 7일간으로 하였으며, 효소액은 이 배양체에 100m㏖ 인산나트륨완충액(pH 7.0) 30㎖를 넣고 4℃에서 5시간가량 방치 후 거즈로 거르고 그 액을 12,000 rpm으로 15분간 원심분리한 상등액을 이용하였다.Here, the microorganisms used in the present invention were selected from 122 kinds of microorganisms isolated from doenjang by the present inventors, and the selection criteria were the highest in β-glucosidase activity. The microorganisms selected were identified as Aspergillus kawachii. The microorganism was inoculated in a sterilized medium by kneading 10 g of wheat bran and 10 ml of 1% glucose solution into a 100 ml Erlenmeyer flask, and autoclaving at 121 ° C. for 15 minutes. Cultivation was carried out for 25 days at 100 ° C, 100 rpm shaking, which was the most active condition for enzyme production, and the enzyme solution was placed in 30 ml of 100 mmol sodium phosphate buffer solution (pH 7.0) for 5 hours at 4 ° C and filtered with gauze. The supernatant was centrifuged at 12,000 rpm for 15 minutes.

이때, 상기 미생물을 감초, 또는 감초추출물에 직접처리하여 배양하거나, 또는 상기 방법에 의하여 얻은 미생물 효소액을 감초, 또는 감초추출물에 처리할 수 있다. 우선 감초를 수집하여 이물질을 제거한 다음 잘게 자르거나 부수고, 이를 실온 내지 100℃, 바람직하게는 100℃에서 2시간 내지 24시간, 바람직하게는 5시간 동안 열수, 또는 에탄올(바람직하게는 95% 에탄올)로 추출한 후 추출물을 동결건조, 증류, 또는 감압증류, 또는 스프레이 드라이에 의해 건조한다. At this time, the microorganism may be treated directly with licorice or licorice extract, or the microbial enzyme solution obtained by the above method may be treated with licorice or licorice extract. First, licorice is collected to remove foreign matter, and then finely chopped or crushed, and then hot water or ethanol (preferably 95% ethanol) for 2 to 24 hours, preferably 5 hours at room temperature to 100 ° C, preferably 100 ° C. After extraction, the extract is dried by lyophilization, distillation, distillation under reduced pressure, or spray drying.

이렇게 얻은 건조물에 대하여, 예를 들어 동결건조한 감초의 수추출물을 100㎎/㎖의 농도로 물에 분산시킨 다음, 상기한 방법으로 얻은 미생물 배양액으로부터 얻은 효소액 1∼100㎖[바람직하게는 감초추출물 1mg당 조효소액 1∼10㎖(단백질로서 약 100∼100㎍)]을 처리하고 이 반응액을 20-50℃에서(바람직하게는 37℃) 10분-36시간(바람직하게는 1시간-12시간) 배양한다.For the dried product thus obtained, for example, the water extract of lyophilized licorice was dispersed in water at a concentration of 100 mg / ml, and then 1-100 ml of enzyme solution obtained from the microbial culture obtained by the above-mentioned method (preferably 1 mg of licorice extract). 1-10 mL of sugar coenzyme solution (about 100-100 μg as protein)] and the reaction solution at 20-50 ° C. (preferably 37 ° C.) for 10 minutes-36 hours (preferably 1 hour-12 hours). ) Incubate.

한편, 대조군으로서는 가열하여 불활성화시킨 효소액을 처리한 것과 아무것도 처리하지 않은 감초수추출물을 이용한다. 이러한 방법에 의하여 제3도 및 4도에 제시한 것과 같이 미생물 효소액을 처리하지 않거나, 불활성화된 미생물효소액을 처리하는 경우에는 매우 작았던 리퀴리티게닌 피크가 처리에 의하여 매우 증가한 것을 목격할 수 있다. 미생물 효소액 처리에 의하여 제5도에 나타낸 것과 같이 시간에 따라 리퀴리티게닌의 생성이 증가하는 것을 목격할 수 있었으며, 약 60분간의 반응에서 거의 최대 함량에 도달하였다.On the other hand, as a control, a treatment with an enzyme solution heated and inactivated and a licorice extract without any treatment are used. By this method, when the microbial enzyme solution is not treated as shown in FIGS. 3 and 4, or when the inactivated microbial enzyme solution is treated, a very small liquirithigenin peak can be observed by the treatment. have. As shown in FIG. 5 by the microbial enzyme solution treatment, the production of liquirithiinin increased with time, and the maximum content was reached in about 60 minutes of reaction.

이후에, 새로이 생성된 피크를 분리하기 위하여 미생물, 또는 미생물 효소액을 처리한 반응액에 2내지 10배량(바람직하게는 5배량)의 에탄올을 가하여 에탄올 가용부와 불용부로 나눈다. 그리고, 에탄올 가용부를 모아 증류, 또는 감압증류, 또는 스프레이 드라이에 의한 건조 후 건조물에 3배량의 물을 가하여 분산시킨 다음, 여기에 적당량의 디클로로메탄, 클로로포름, 에틸아세테이트, 에테르, 에탄올(바람직하게는 디클로로메탄)으로 분배추출한다. Thereafter, 2-10 times (preferably 5 times) of ethanol is added to the reaction solution treated with the microorganism or microbial enzyme solution to separate the newly generated peaks, and the ethanol is divided into soluble and insoluble portions. Then, the ethanol soluble portion is collected, and after distillation, distillation under reduced pressure, or drying by spray drying, 3 times the amount of water is added to the dried product and dispersed therein, and an appropriate amount of dichloromethane, chloroform, ethyl acetate, ether, ethanol (preferably Partitioned dichloromethane).

이때, 상기 추출액을 증류, 감압증류, 또는 스프레이 드라이어에 의한 건조 후 실리카젤, 역상 실리카젤, Sephadex, 바람직하게는 실리카젤을 이용한 컬럼크로마토그라피 등에 의하여 분리하여 함량이 늘어난 리퀴리티게닌이 다량 함유된 분획을 얻는다. 순수한 리퀴리티게닌은 이 분획을 메탄올, 에탄올, 물, 디클로로메탄, 벤젠, 에틸아세테이트, 또는 이들의 혼합용매로부터 재결정화하여 얻을 수 있다.At this time, the extract is distilled, distilled under reduced pressure, or dried by a spray dryer, and then separated by silica gel, reverse phase silica gel, Sephadex, preferably column chromatography using silica gel, etc. Obtained fractions. Pure liquiditinine can be obtained by recrystallization of this fraction from methanol, ethanol, water, dichloromethane, benzene, ethyl acetate, or a mixed solvent thereof.

상기한 바와 같이 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액 처리에 의하여 감초, 또는 감초추출물 중 함량이 매우 증가된 화합물은 제5도와 제6도에 나타낸 핵자기공명스펙트럼의 결과 리퀴리티게닌이 나타내는 특성과 정확히 일치하였으므로 이 화합물을 리퀴리티게닌으로 동정하였다.As described above, the microorganisms having a sugar hydrolytic activity, or the compound of which licorice or licorice extract is greatly increased by the microbial enzyme solution treatment, are the result of the nuclear magnetic resonance spectrum shown in FIG. 5 and FIG. This compound was identified as liquirithigenin because it exactly coincided with the properties indicated.

이렇듯, 상기 예시한 방법을 이용할 경우 최대 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리한 감초추출물 1kg 당 약 0.5g의 리퀴리티게닌을 얻을 수 있다.As such, when the above-described method is used, about 0.5 g of liquirithiinine per kg of licorice extract treated with the microorganism having the maximum hydrolytic activity or its microbial enzyme solution can be obtained.

본 발명의 리퀴리티게닌은 상기한 바와 같은 분광학적 성질을 가지고 있으며 항치매, 항산화, 항암, 항균, 해독 등의 생리활성을 가지는 화합물로 감초 뿐 아니라 유사 식물류의 미생물, 또는 미생물 효소액 처리에 의해서도 만들어질 수 있으며, 또한 본 발명에 이용된 Aspergyllus kawachii와 이 미생물유래의 효소액 이외에 유사한 기능을 갖는 미생물, 또는 효소액을 사용해서도 같은 결과를 얻을 수 있으므로 본 발명의 상기 화합물의 함량을 높이는 방법은 특히 감초와 Aspergillus kawachii나 그효소액을 이용하는 방법에만 한정되는 것은 아니다.Liquirithiinin of the present invention has the spectroscopic properties as described above, and has a biological activity such as anti-dementia, antioxidant, anti-cancer, antibacterial, detoxification, etc., not only licorice but also by treating microorganisms of similar plants or microbial enzyme solution. In addition, since the same result can be obtained using Aspergyllus kawachii and microorganisms having similar functions in addition to the enzyme solution derived from this microorganism or the enzyme solution used in the present invention, the method of increasing the content of the compound of the present invention is particularly Licorice and Aspergillus kawachii or its enzyme solution is not limited only.

본 발명은 기재된 실시예에 한정되는 것은 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명하다. 따라서 그러한 변형예 또는 수정예들은 본 발명의 특허청구범위에 속한다 해야 할 것이다.It is apparent to those skilled in the art that the present invention is not limited to the described embodiments, and that various modifications and variations can be made without departing from the spirit and scope of the present invention. Therefore, such modifications or variations will have to belong to the claims of the present invention.

이상에서 설명한 바와 같이 본 발명은 감초 또는 감초추출물로부터 항치매, 항균, 항산화, 항혈관신생, 항피부암, 카드뮴 유발 독성제거 등의 활성화합물인 리퀴리티게닌(liquiritigenin) 추출물 함량을 증강하고, 이 추출물로부터 활성화합물(리퀴리티게닌)을 정제하는 방법을 제공함으로서, 항치매, 항산화, 항암, 항균, 해독등의 기능을 갖는 건강기능성 식품 조성물 및 치료와 예방을 위한 약학적 조성물 그리고 노화방지, 자외선차단 등의 기능을 갖는 기능성 향장품을 제공하는 효과를 제공한다.As described above, the present invention enhances the content of liquiritigenin extract, which is an active compound such as anti-dementia, antibacterial, antioxidant, antiangiogenic, anti-skin cancer, and cadmium-induced toxicity removal from licorice or licorice extract. By providing a method for purifying the active compound (liquirithiinin) from the extract, a health functional food composition having the functions of anti-dementia, antioxidant, anti-cancer, antibacterial, detoxification, pharmaceutical compositions for treatment and prevention and anti-aging, It provides the effect of providing a functional cosmetics having a function such as UV protection.

Claims (4)

감초를 잘게 세절한 후 100℃에서 물로 환류추출하여 여과한 뒤 여액을 동결건조하는 단계와;Finely slicing licorice and filtering the mixture by refluxing with water at 100 ° C. and then freezing and drying the filtrate; 상기 단계에 의해 동결건조한 건조물을 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액으로 처리한 후 20∼50℃에서 10분∼36시간 정치하는 단계와;Treating the lyophilized dried product by the above step with a microorganism having a sugar hydrolytic activity, or a microbial enzyme solution thereof, and then leaving the sample to stand at 20 to 50 ° C. for 10 minutes to 36 hours; 상기 단계에 의해 배양된 배양물에 2배 내지 10배량의 에탄올을 가하여 에탄올 가용부와 불용부로 나눈 후 에탄올 가용부를 감압농축하여 추출물을 얻는 단계와; Adding 2 to 10 times the amount of ethanol to the culture cultured by the above step and dividing the ethanol soluble part and the insoluble part into ethanol soluble part to obtain an extract under reduced pressure; 상기 단계에 의해 얻어진 추출물을 증류수에 분산하여 디클로로메탄으로 3회 분배 추출한 후 가용성 분획을 농축하는 단계와;Dispersing the extract obtained by the above step in distilled water, extracting three times with dichloromethane, and concentrating the soluble fraction; 상기 단계에 의해 농축된 디클로로메탄 가용성 분획에 대하여 실리카젤 컬럼크로마토그라피하여 7개의 분획을 얻는 단계와;Silica gel column chromatography on the dichloromethane soluble fraction concentrated by the above step to obtain seven fractions; 상기 단계에 의해 분획된 7번째 분획을 디클로로메탄과 메탄올의 혼합용매에서 재결정화를 행하여 순수한 리퀴리티게닌을 얻는 단계;로 진행함을 특징으로 하는 감초의 리퀴리티게닌 추출물 함량을 증강하는 방법.Recrystallizing the seventh fraction fractionated by the above step in a mixed solvent of dichloromethane and methanol to obtain a pure liquirithigenin; a method of enhancing the content of the liquiritigenin extract of licorice . 제 1항에 있어서,The method of claim 1, 상기 리퀴리티게닌(liquritigenin) 함량이 증강된 감초, 또는 감초의 추출물에 담체, 부형체, 희석제 등을 포함시켜 항치매, 항암, 노화방지, 항균, 해독제의 제조가 가능하도록 함을 특징으로 하는 감초의 리퀴리티게닌 추출물 함량을 증강하 는 방법.Liquritigenin (liquritigenin) content of the licorice, or licorice extract is enhanced by including a carrier, excipients, diluents, etc. characterized in that the production of anti-dementia, anti-cancer, anti-aging, antibacterial, antidote How to enhance the liquirithigenin extract content of licorice. 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리한 감초를 열수 또는 에탄올로 추출하거나, 감초를 열수, 또는 에탄올로 추출한 후 농축하여 추출물에 대하여 당가수분해활성을 갖는 미생물, 또는 그 미생물 효소액을 처리하여 조추출물을 얻는 단계와;Microorganisms having a sugar hydrolytic activity or licorice treated with the microbial enzyme solution were extracted with hot water or ethanol, licorice was extracted with hot water or ethanol and concentrated to extract microorganisms having a sugar hydrolytic activity against the extract, or microbial enzyme liquid Processing to obtain a crude extract; 상기 단계에 의해 얻어진 조추출물을 그대로 사용하거나, 에탄올에 분산시켜 에탄올 가용부와 불용부로 나누는 단계와;Using the crude extract obtained by the step as it is or dispersing it in ethanol and dividing it into an ethanol soluble portion and an insoluble portion; 상기 단계에 의해 분리된 에탄올 가용부를 농축한 후 물에 분산시켜 디클로로메탄, 클로로포름, 에틸아세테이트로 분배 추출한 뒤 농축하여 유기용매 가용성 분획을 얻은 단계와;Concentrating the ethanol soluble part separated by the above step, dispersing in water, partitioning extraction with dichloromethane, chloroform, ethyl acetate, and concentrating to obtain an organic solvent soluble fraction; 상기 단계에 의해 분리된 유기용매 가용성 분획을 농축하여 실리카젤, 역상실리카젤, 고속액체, 세파덱스 크로마토그라피를 이용하여 항치매, 항산화, 항암, 항균, 해독 활성을 갖는 리퀴리티게닌을 정제하는 단계;로 진행됨을 특징으로 하는 감초의 리퀴리티게닌 추출물에서의 활성화합물 정제방법.Concentrating the organic solvent soluble fraction separated by the above step to purify the liqueuritinin having anti-dementia, antioxidant, anti-cancer, antibacterial, detoxification activity using silica gel, reversed phase silica gel, high-speed liquid, Sephadex chromatography Purification method of the active compound in the liquirithynin extract of licorice, characterized in that proceeded to. 제 3항에 있어서,The method of claim 3, wherein 상기 리퀴리티게닌은 메탄올, 헥산, 에틸아세테이트, 초산, 개미산, 클로로포름, 벤젠 또는 이들의 혼합용매와 실리카젤, Sephadex 등의 담체를 이용한 각종 크로마토그라피를 사용하여 감초의 리퀴리티게닌 추출물로부터 정제됨을 특징으로 하는 감초의 리퀴리티게닌 추출물에서의 활성화합물 정제방법.The liquiditinine is purified from the extract of liquiritinin from licorice using methanol, hexane, ethyl acetate, acetic acid, formic acid, chloroform, benzene, or various chromatographies using a mixed solvent thereof and a carrier such as silica gel and Sephadex. Purification method of the active compound in the liquirithigenin extract of licorice.
KR1020040056020A 2004-07-19 2004-07-19 Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them KR100592482B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040056020A KR100592482B1 (en) 2004-07-19 2004-07-19 Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040056020A KR100592482B1 (en) 2004-07-19 2004-07-19 Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them

Publications (2)

Publication Number Publication Date
KR20060039036A KR20060039036A (en) 2006-05-08
KR100592482B1 true KR100592482B1 (en) 2006-06-26

Family

ID=37146379

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040056020A KR100592482B1 (en) 2004-07-19 2004-07-19 Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them

Country Status (1)

Country Link
KR (1) KR100592482B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010013987A3 (en) * 2008-08-01 2010-05-27 Daewon Pharm., Co., Ltd Extraction method for increasing liquiritigenin content in glycyrrhizae radix et rhizoma or glycyrrhizae radix extract
KR101101296B1 (en) 2009-11-09 2012-01-04 한림대학교 산학협력단 A method for isolation of antioxidant from glycyrrhiza uralensis
KR102079794B1 (en) 2018-09-18 2020-02-20 전북대학교산학협력단 Novel Enterococcus faecium microorganism and its use thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5275241B2 (en) * 2007-09-03 2013-08-28 春男 肥後 Cancer cell growth inhibitor containing liquiritigenin
CN101152173A (en) * 2007-10-15 2008-04-02 崔福贵 Use of liquiritigenin in preparing medicament for treating neurodegenerative diseases
KR101287821B1 (en) * 2011-01-03 2013-07-26 한국식품연구원 Composition for invigorating GABAA-benzodiazepine receptor and composition for improving hypnotic effects comprising Isoliquiritigenin
KR101581240B1 (en) * 2014-07-02 2015-12-31 (주) 노바렉스 Preparation method of extract of licorice containing Glycyrrhizic acid and Liquiritin
JP7079909B2 (en) * 2017-09-07 2022-06-03 池田食研株式会社 Manufacturing method of enzyme-treated licorice extract
KR102212800B1 (en) * 2019-02-13 2021-02-08 청운대학교산학협력단 Manufacturing method of fermented liquid of liquorice extract with increased amount of bioactive phytoestrogen and enriched calcium and the fermented liquid produced therefrom
KR102227963B1 (en) 2019-04-08 2021-03-16 한국한의약진흥원 Antiangiogenic composition comprising bioconverted herbal composition, and its preparation method
KR102210502B1 (en) * 2019-06-19 2021-02-01 영남대학교 산학협력단 Composition for preventing or treating muscular diseases
WO2020256397A1 (en) * 2019-06-19 2020-12-24 영남대학교 산학협력단 Composition for preventing or treating muscular diseases, containing, as active ingredient, glycyrrhiza uralensis extract or compound isolated therefrom
KR102579928B1 (en) * 2021-04-09 2023-09-18 주식회사 케이엠에프 Manufacturing method of herbal mixture extract with enhanced content of liquiritin, liquiritigenin and atractylenolide Ⅲ

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63104920A (en) 1986-10-21 1988-05-10 Tsumura & Co Aldose reactase inhibitor
US5032580A (en) 1987-12-28 1991-07-16 Sanyo-Kokusaku Pulp Co., Ltd. Compositions for activirus medicines
KR20050032807A (en) * 2003-10-02 2005-04-08 재단법인서울대학교산학협력재단 Composition comprising extract of glycyrrhizae radix or liquiritigenin for the treatment and prevention of diseases caused by heavy metal poisoning

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63104920A (en) 1986-10-21 1988-05-10 Tsumura & Co Aldose reactase inhibitor
US5032580A (en) 1987-12-28 1991-07-16 Sanyo-Kokusaku Pulp Co., Ltd. Compositions for activirus medicines
KR20050032807A (en) * 2003-10-02 2005-04-08 재단법인서울대학교산학협력재단 Composition comprising extract of glycyrrhizae radix or liquiritigenin for the treatment and prevention of diseases caused by heavy metal poisoning

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
논문

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010013987A3 (en) * 2008-08-01 2010-05-27 Daewon Pharm., Co., Ltd Extraction method for increasing liquiritigenin content in glycyrrhizae radix et rhizoma or glycyrrhizae radix extract
KR101101296B1 (en) 2009-11-09 2012-01-04 한림대학교 산학협력단 A method for isolation of antioxidant from glycyrrhiza uralensis
KR102079794B1 (en) 2018-09-18 2020-02-20 전북대학교산학협력단 Novel Enterococcus faecium microorganism and its use thereof

Also Published As

Publication number Publication date
KR20060039036A (en) 2006-05-08

Similar Documents

Publication Publication Date Title
KR100592482B1 (en) Methods for increasing liquiritigenin content in a licorice and its extracts and the method for the isolation and extraction of liquiritigenin from them
US8940789B2 (en) Neurite elongation agent, memory-improving agent and anti-Alzheimer agent comprising 4′-demethylnobiletin or 4′-demethyltangeretin as active ingredient, and process for production of the compound
Oh et al. Glycosidase inhibitory phenolic compounds from the seed of Psoralea corylifolia
US6991811B1 (en) Echinacea induction of phase II enzymes
Jan et al. Evaluation of antidiabetic potential of steroidal alkaloid of Sarcococca saligna
KR20090097440A (en) METHOD FOR PREPARING CAFFEIC ACID IMPROVING gamma-GCS ACTIVITY, THE CAFFEIC ACID PREPARED THEREFROM, AND A FOOD COMPOSITION AND A PHARMACEUTICAL COMPOSITION COMPRISING THE CAFFEIC ACID
KR100902669B1 (en) A method for isolation and purification of calycosin from Astragali Radix
CN103408528B (en) Chroman compound, as well as preparation method and application thereof
KR100313323B1 (en) Method for Extraction Isolation and Identification of trans-Resveratrol from Paeonia lactiflora Seeds
KR20150034680A (en) Coriolus versicolor extracts, methods of isolating biologically-active compounds, and uses thereof
CN115154453A (en) Application of aspulvinone compound in preparation of antidiabetic drugs
KR102169156B1 (en) Method for increasing platycodin E content in Platycodon grandiflorum using Aspergillus shirousamii
KR100863217B1 (en) A method for isolation and purification of calycosin and formononetin from Astragali Radix
KR101084733B1 (en) Liver cytoprotective composition comprising an extract from the stem barks of alnus hirsuta and compounds isolated therefrom
KR101293835B1 (en) Composition comprising the combined extract of Astragalus membranaceus Bunge and Plantago asiatica for preventing and treating obesity
KR100765419B1 (en) Health care composition comprising saucerneol b isolated from saururus chinensis for the prevention and alleviation of inflammatory, allergy and asthma diseases
KR101866372B1 (en) Pharmaceutical composition for preventing or treating obesity, comprising a compounds derived from an extract or fraction or Juglans mandshurica
WO2022260312A1 (en) Composition for preventing, ameliorating or treating osteoporosis comprising fermented aurea helianthus product using bacillus sp. strain
KR100200182B1 (en) Composition having liver-protecting effect, which contains isoflavone isolated from astragalus membranaceus
WO2017220051A2 (en) Benserazide hydrochloride pharmaceutical composition and medical use thereof for lowering blood sugar
KR100765436B1 (en) Methods for increasing aurantio-obtusin content in Cassiae Semen, and the method for extraction of aurantio-obtusin having increased contents
KR101440855B1 (en) A composition comprising known compounds isolated from the extract of pine tree leaf for the prevention and treatment of cancer diseases
KR20210014182A (en) Composition Comprising the Extract of Cirsium maackii for Preventing or Treating Liver Injury Induced Hepatotoxic Substances
CN104306369B (en) A kind of chroman compound and its extracting method and application
KR20220048568A (en) A composition for preventing or treating alcoholic liver disease comprising an extract mixture

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120111

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20140407

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20170407

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20180406

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20190610

Year of fee payment: 14